TL4830031
TL4830031 (compound 8i), a quinolone antibiotic derivatives, is a potent Axl inhibitor with an IC50 value of 26 nM. TL4830031 inhibits the phosphorylation of Axl. TL4830031 inhibits cell invasion and migration. TL4830031 can be used for cancer research[1].
Product Specifications
CAS Number
[2084107-15-1]
UNSPSC
12352005
Target
TAM Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tl4830031.html
Purity
98.0
Solubility
DMSO : 2.38 mg/mL (ultrasonic; warming; adjust pH to 5 with HCl; heat to 60°C)
Smiles
O=C(C1=CN2C3=C(CCC2C)C(N4CCC(CC4)O)=C(F)C=C3C1=O)NC5=CC=C(C(F)=C5)OC6=NC=NC7=C6C=C(OC)C(OC)=C7
Molecular Formula
C35H33F2N5O6
Molecular Weight
657.66
References & Citations
[1]Tan L, et, al. Quinolone antibiotic derivatives as new selective Axl kinase inhibitors. Eur J Med Chem. 2019 Mar 15;166:318-327.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Axl
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Delftia acidovorans 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Recombinant Delftia acidovorans 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Recombinant Delftia acidovorans 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Recombinant Delftia acidovorans 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Recombinant Delftia acidovorans 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)